Mechanism of action of serotonin selective reuptake inhibitors
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 51 (3) , 215-235
- https://doi.org/10.1016/s0165-0327(98)00221-3
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockadeNeuroscience Letters, 1996
- Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysisLife Sciences, 1994
- Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nucleiBrain Research, 1994
- Sexual Dysfunction Associated with the Drug Treatment of Psychiatric DisordersCNS Drugs, 1994
- Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and FluorouracilNew England Journal of Medicine, 1993
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatumLife Sciences, 1992
- Clinical evaluation of 5-HT3 receptor antagonists as anti-emeticsTrends in Pharmacological Sciences, 1991
- Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?Neuroscience Letters, 1991
- 5-HT1A Partial AgonistsDrugs, 1991